Table 3. Quality Scores using AGREE II Instruments for included CPGs on OA.
| Agree II domains | AAOS | ACR | Eular | Eular | Kjeken et al. | NICE | OARSI | Ottawa Panel | Peter et al. | Philadephia Panel | RACGP | Roddy et al. | (mn ±SD) |
| [26] | [27] | [28]–[30] | [31] | [32] | [33] | [34] | [35]–[39] | [42] | [40]–[41] | [44] | [43] | ||
| Domain 1 | 78% | 89% | 31% | 56% | 56% | 67% | 56% | 97% | 56% | 97% | 81% | 75% | 70%±20% |
| Domain 2 | 61% | 72% | 28% | 78% | 19% | 89% | 67% | 72% | 67% | 67% | 75% | 39% | 61%±21% |
| Domain 3 | 80% | 67% | 54% | 57% | 52% | 70% | 78% | 65% | 45% | 70% | 62% | 55% | 63%±11% |
| Domain 4 | 89% | 92% | 89% | 89% | 86% | 81% | 89% | 61% | 97% | 78% | 89% | 89% | 86%±9% |
| Domain 5 | 0% | 10% | 17% | 0% | 0% | 56% | 27% | 10% | 0% | 25% | 21% | 0% | 14%±16% |
| Domain 6 | 67% | 29% | 8% | 13% | 33% | 25% | 67% | 42% | 21% | 17% | 21% | 33% | 31%±19% |
| Quality of CPGs (mn±SD) | 5.5±0.71 | 4.5±0.71 | 4±0 | 4.5±0.71 | 4±0 | 5.5±0.71 | 4±0 | 5.5±0.71 | 4±0 | 5±0 | 6±1.41 | 5±0 | 4.8±0.41 |
| Assessed by | PR & KTA | PR &LB | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA | PR & KTA |
Domain 1. Scope and Purpose; Domain 2: Stakeholder involvement; Domain 3: Rigour of Development; Domain 4: Clarity of Presentation; Domain 5; Applicability Domain 6: Editorial Independence; Quality of CPGs: Using AGREE II scoring system :1–7; ACR: American College of Rheumatology; EULAR: The European League against rheumatism; NICE: National Institute for health and Clinical Excellence; OARSI: Osteoarthritis Research Society International; PGrip: People Getting A Grip on Osteoarthritis; RACGP: Royal Australian College of General Practitioners; mn: mean; SD: standard deviation.